All In Biotech

NDA 017450 · Medtech Products

Monistat 7

Miconazole Nitrate · Vaginal

Novel

Last checked: Nov 20, 2026Latest source record: Jul 22, 2020 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1974

Jan 30, 1974

Approved uses

3

Original approval plus efficacy supplements

Registered trials

36

8 Phase 3, 0 recruiting

FAERS reports

3,456

946 serious, 88 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Oct 27, 2025.

Uses treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Apr 26, 1993 Supplement 38 · Efficacy
  • Feb 15, 1991 Supplement 35 · Efficacy
  • Jan 30, 1974 Original approval · Type 1 - New Molecular Entity
1 products under this application
  • MONISTAT 7 · MICONAZOLE NITRATE 2% · CREAM, VAGINAL · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Miconazole Nitrate" as an intervention, any sponsor and status, largest first.

All 36 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • vulvovaginal burning sensation1,028
  • vulvovaginal pain732
  • drug ineffective380
  • vulvovaginal pruritus365
  • vaginal haemorrhage362
  • vulvovaginal discomfort269
  • condition aggravated224
  • vulvovaginal swelling204
  • pain141
  • burning sensation116
  • pruritus112
  • abdominal pain94

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
200423
200524
200625
200721
200847
200976
201049
201159
201281
201325
201434
201542
2016181
2017150
2018325
2019288
2020265
2021329
2022292
2023213
2024285
2025330
2026292

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 71 on PubMed

Sponsor: Medtech Products

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.